Clinical Trials Using P-glycoprotein Inhibitor HM30181AK
Clinical trials are research studies that involve people. The clinical trials on this list are studying P-glycoprotein Inhibitor HM30181AK. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A DRF Study to Evaluate Safety, Tolerability, PK, and Activity of Oradoxel Monotherapy in Subjects w Adv. Malignancies
This is a nonrandomized, open-label, dose escalation, safety, activity, and PK study to determine the MTD and optimal dosing regimen of Oradoxel. No control group has been included.
Location: 3 locations
Evaluate Eribulin ORA in Subjects With Solid Tumors
This is a nonrandomized, open-label, dosed escalation, safety activity, and PK study to determine the MTD and optimal dosing regimen of Eribulin ORA.
Location: Roswell Park Cancer Institute, Buffalo, New York